Literature DB >> 20572822

Phacoemulsification in posterior polar cataract: does size of lens opacity affect surgical outcome?

Sunil Kumar1, Jagat Ram, Jaspreet Sukhija, Saurabh Severia.   

Abstract

BACKGROUND: To study the effect of size of the posterior polar opacity on surgical and visual outcome of phacoemulsification in posterior polar cataract.
SETTING: Post Graduate Institute of Medical Education and Research, Chandigarh, India.
METHODS: Consecutive patients with posterior polar cataract who underwent phacoemulsification were analysed for intraoperative complications and postoperative outcome. The continuous curvilinear capsulorhexis size was kept approximately 5.5 mm, and hydrodelineation was done instead of hydrodissection.
RESULTS: There were 58 eyes of 51 patients who underwent phacoemulsification for posterior polar cataract. The mean follow-up time was 15.4 months (range 12-40 months). Twenty-three eyes had size of polar opacities 4 mm or more in diameter whereas 35 eyes had less than 4 mm. Posterior capsule rupture occurred in nine eyes (15.51%). In eyes with polar opacities 4 mm or more, seven (30.43%) had posterior capsule rupture whereas in eyes with less than 4 mm size, only two (5.71%) had posterior capsule rupture. Capsular bag placement of intraocular lens (IOL) was achieved in 50 eyes and sulcus-sulcus in eight eyes. Three-piece hydrophobic acrylic IOL was implanted in 47 eyes and all polymethylmethacrylate IOL in 11 eyes. Postoperatively best-corrected visual acuity of 6/12 or better was achieved in 55 eyes (94.8%) and three eyes achieved 6/24 or less.
CONCLUSION: Phacoemulsification in eyes with larger size of polar opacity has significant risk of posterior capsule rupture.
© 2010 The Authors. Clinical and Experimental Ophthalmology © 2010 Royal Australian and New Zealand College of Ophthalmologists.

Entities:  

Mesh:

Year:  2010        PMID: 20572822     DOI: 10.1111/j.1442-9071.2010.02354.x

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  9 in total

Review 1.  Surgical approaches to posterior polar cataract: a review.

Authors:  A R Vasavada; S M Raj; V Vasavada; S Shrivastav
Journal:  Eye (Lond)       Date:  2012-03-23       Impact factor: 3.775

2.  Posterior polar cataract: A review.

Authors:  Hatem Kalantan
Journal:  Saudi J Ophthalmol       Date:  2011-05-07

3.  Posterior polar cataract: Minimizing risks.

Authors:  Gaurav Kapoor; Sankalp Seth; T S Ahluwalia; S K Dhar
Journal:  Med J Armed Forces India       Date:  2016-05-25

Review 4.  Managing the posterior polar cataract: An update.

Authors:  Abhay R Vasavada; Vaishali A Vasavada
Journal:  Indian J Ophthalmol       Date:  2017-12       Impact factor: 1.848

5.  Application of 25 MHz B-Scan Ultrasonography to Determine the Integrity of the Posterior Capsule in Posterior Polar Cataract.

Authors:  Yawen Guo; Chengzhe Lu; Bin Wu; Jianmin Gao; Jun Li; Xiaoyong Yuan; Xin Tang
Journal:  J Ophthalmol       Date:  2018-03-26       Impact factor: 1.909

6.  Morphological variations influencing the outcomes in posterior polar cataract.

Authors:  P R Aswin; Kandukuri Harika; Madhu Shekhar; R Sankarananthan; Amish Shah; P Lakshmanan; Haripriya Aravind
Journal:  Indian J Ophthalmol       Date:  2022-07       Impact factor: 2.969

7.  Phacoemulsification in posterior polar cataract: Experience from a tertiary eye care Centre in North India.

Authors:  Chintan Malhotra; Deepika Dhingra; Nishant Nawani; Partha Chakma; Arun K Jain
Journal:  Indian J Ophthalmol       Date:  2020-04       Impact factor: 1.848

8.  Commentary: Pearls in posterior polar cataract.

Authors:  Manas Nath; Annamalai Odayappan
Journal:  Indian J Ophthalmol       Date:  2020-04       Impact factor: 1.848

9.  Krüppel-like factor 1 (KLF1) promoted the proliferation, migration and invasion of human lens epithelial cells by enhancing the expression of Zinc Finger and BTB Domain Containing 7A (ZBTB7A) and activating Wnt/β-catenin pathway.

Authors:  Guangming Shi; Feng Yang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.